Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,279,000 | 785,000 | 562,527 | 63,787 | 150,236 |
| Depreciation Amortization | 370,000 | 353,000 | 295,449 | 274,955 | 428,091 |
| Income taxes - deferred | -110,000 | -74,000 | -149,001 | -196,644 | 29,357 |
| Accounts receivable | -128,000 | -363,000 | -146,892 | -110,237 | -59,512 |
| Other Working Capital | 130,000 | -237,000 | 169,774 | -132,329 | -127,023 |
| Other Operating Activity | 822,000 | 731,000 | 510,264 | 688,168 | 59,478 |
| Operating Cash Flow | $2,363,000 | $1,195,000 | $1,242,121 | $587,700 | $480,627 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,400,000 | -650,000 | -321,955 | -322,832 | -213,351 |
| Purchase Of Investment | -1,000,000 | -890,000 | -1,760,220 | -812,734 | -1,565,060 |
| Sale Of Investment | 722,000 | 1,149,000 | 739,867 | 1,746,198 | 1,084,546 |
| Purchase Sale Intangibles | -45,000 | -64,000 | N/A | N/A | N/A |
| Other Investing Activity | -98,000 | -59,000 | -61,307 | -617,125 | -10,105 |
| Investing Cash Flow | $-1,776,000 | $-450,000 | $-1,403,615 | $-6,493 | $-703,970 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,988,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -425,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 821,000 | 505,000 | 526,861 | 74,164 | 106,866 |
| Common Stock Repurchased | -2,016,000 | -1,352,000 | -201,345 | -692,752 | -39,704 |
| Other Financing Activity | 0 | 0 | 0 | -149,692 | 0 |
| Financing Cash Flow | $368,000 | $-847,000 | $325,516 | $-768,280 | $67,162 |
| Beginning Cash Position | 270,000 | 372,000 | 208,130 | 395,203 | 551,384 |
| End Cash Position | 1,225,000 | 270,000 | 372,152 | 208,130 | 395,203 |
| Net Cash Flow | $955,000 | $-102,000 | $164,022 | $-187,073 | $-156,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,363,000 | 1,195,000 | 1,242,121 | 587,700 | 480,627 |
| Capital Expenditure | -1,400,000 | -650,000 | -321,955 | -322,832 | -213,351 |
| Free Cash Flow | 963,000 | 545,000 | 920,166 | 264,868 | 267,276 |